These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 27196626

  • 21. The Photobiomodulation effect of 980 nm Diode Laser on Patients with Xerostomia.
    Derikvand N, Basirat M, Ghasemi SS, Hashemi R.
    Lasers Med Sci; 2023 Dec 20; 39(1):10. PubMed ID: 38117359
    [Abstract] [Full Text] [Related]

  • 22. Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients - a triple blinded randomized controlled trial.
    Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Vadhiraja BM.
    Radiother Oncol; 2012 Sep 20; 104(3):349-54. PubMed ID: 22884841
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of the salivary function of patients in treatment with radiotherapy for head and neck cancer submitted to photobiomodulation.
    Ribeiro LN, Lima MH, Carvalho AT, Albuquerque RF, Leão JC, Silva IH.
    Med Oral Patol Oral Cir Bucal; 2021 Jan 01; 26(1):e14-e20. PubMed ID: 33247577
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Impact of low-level laser therapy on the quality of life of patients with xerostomia undergoing head and neck radiotherapy: a systematic review.
    Ribeiro LN, de Vasconcelos Carvalho M, de Oliveira Limirio JPJ, do Egito Vasconcelos BC, Moraes SLD, Pellizzer EP.
    Support Care Cancer; 2024 Jan 20; 32(2):118. PubMed ID: 38244087
    [Abstract] [Full Text] [Related]

  • 28. Xerostomia following radiotherapy of the head and neck affects vocal function.
    Roh JL, Kim AY, Cho MJ.
    J Clin Oncol; 2005 May 01; 23(13):3016-23. PubMed ID: 15860858
    [Abstract] [Full Text] [Related]

  • 29. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI, Chambers MS, Weber RS, Eisbruch A.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [Abstract] [Full Text] [Related]

  • 30. Use of 660-nm diode laser in the prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy.
    Zanin T, Zanin F, Carvalhosa AA, Castro PH, Pacheco MT, Zanin IC, Brugnera A.
    Photomed Laser Surg; 2010 Apr 01; 28(2):233-7. PubMed ID: 19764899
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study.
    Lakshman AR, Babu GS, Rao S.
    J Cancer Res Ther; 2015 Apr 01; 11(1):229-33. PubMed ID: 25879367
    [Abstract] [Full Text] [Related]

  • 32. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
    Vacha P, Marx M, Engel A, Richter E, Feyerabend T.
    Strahlenther Onkol; 1999 Nov 01; 175 Suppl 4():18-22. PubMed ID: 10584135
    [Abstract] [Full Text] [Related]

  • 33. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):725-31. PubMed ID: 16199308
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy.
    Oton-Leite AF, Elias LS, Morais MO, Pinezi JC, Leles CR, Silva MA, Mendonça EF.
    Spec Care Dentist; 2013 Nov 01; 33(6):294-300. PubMed ID: 24164228
    [Abstract] [Full Text] [Related]

  • 36. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?
    Vacha P, Fehlauer F, Mahlmann B, Marx M, Hinke A, Sommer K, Richter E, Feyerabend T.
    Strahlenther Onkol; 2003 Jun 01; 179(6):385-9. PubMed ID: 12789464
    [Abstract] [Full Text] [Related]

  • 37. Impact of submandibular gland excision on salivary gland function in head and neck cancer patients.
    Jaguar GC, Lima EN, Kowalski LP, Pellizon AC, Carvalho AL, Alves FA.
    Oral Oncol; 2010 May 01; 46(5):349-54. PubMed ID: 20227906
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient.
    Al-Qahtani K, Hier MP, Sultanum K, Black MJ.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun 01; 101(6):753-6. PubMed ID: 16731395
    [Abstract] [Full Text] [Related]

  • 40. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI, Chao KS, El Naqa I, Franklin GE, Zakarian K, Vicic M, Deasy JO.
    Int J Radiat Oncol Biol Phys; 2005 Jul 15; 62(4):1055-69. PubMed ID: 15990009
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.